The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Clinical Features and Outcome of Patients With IRAK-4 and MyD88 Deficiency
Open accessAbstract
Autosomal recessive interleukin-1 receptor-associated kinase (IRAK)-4 and myeloid differentiation factor (MyD)88 deficiencies impair Toll-like receptor (TLR)- and interleukin-1 receptor-mediated immunity. We documented the clinical features and outcome of 48 patients with IRAK-4 deficiency and 12 patients with MyD88 deficiency, from 37 kindreds in 15 countries.The clinical features of IRAK-4 and MyD88 deficiency were indistinguishable. There were no severe viral, parasitic, and fungal diseases, and the range of bacterial infections was narrow. Noninvasive bacterial infections occurred in 52 patients, with a high incidence of infections of the upper respiratory tract and the skin, mostly caused by Pseudomonas aeruginosa and Staphylococcus aureus, respectively. The leading threat was invasive pneumococcal disease, documented in 41 patients (68%) and causing 72 documented invasive infections (52.2%). P. aeruginosa and Staph. aureus documented invasive infections also occurred (16.7% and 16%, respectively, in 13 and 13 patients, respectively). Systemic signs of inflammation were usually weak or delayed. The first invasive infection occurred before the age of 2 years in 53 (88.3%) and in the neonatal period in 19 (32.7%) patients. Multiple or recurrent invasive infections were observed in most survivors (n = 36/50, 72%).Clinical outcome was poor, with 24 deaths, in 10 cases during the first invasive episode and in 16 cases of invasive pneumococcal disease. However, no death and invasive infectious disease were reported in patients after the age of 8 years and 14 years, respectively. Antibiotic prophylaxis (n = 34), antipneumococcal vaccination (n = 31), and/or IgG infusion (n = 19), when instituted, had a beneficial impact on patients until the teenage years, with no seemingly detectable impact thereafter.IRAK-4 and MyD88 deficiencies predispose patients to recurrent life-threatening bacterial diseases, such as invasive pneumococcal disease in particular, in infancy and early childhood, with weak signs of inflammation. Patients and families should be informed of the risk of developing life-threatening infections; empiric antibacterial treatment and immediate medical consultation are strongly recommended in cases of suspected infection or moderate fever. Prophylactic measures in childhood are beneficial, until spontaneous improvement occurs in adolescence.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Akira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312
Toll-like receptors in innate immunity
Takeda, K. (2004) · International Immunology · doi:10.1093/intimm/dxh186 · Cited by 3,328
Pyogenic Bacterial Infections in Humans with MyD88 Deficiency
von Bernuth, H., Picard, C., Jin, Z., Pankla, R., Xiao, H., Ku, C.-L., Chrabieh, M., Mustapha, I. B., Ghandil, P., Camcioglu, Y., et al. (2008) · Science · doi:10.1126/science.1158298 · Cited by 1,287
Self-citationTLR3 Deficiency in Patients with Herpes Simplex Encephalitis
Zhang, S.-Y., Jouanguy, E., Ugolini, S., Smahi, A., Elain, G., Romero, P., Segal, D., Sancho-Shimizu, V., Lorenzo, L., Puel, A., et al. (2007) · Science · doi:10.1126/science.1139522 · Cited by 1,057
Self-citationDominant-negative mutations in the DNA-binding domain of STAT3 cause hyper-IgE syndrome
Minegishi, Y., Saito, M., Tsuchiya, S., Tsuge, I., Takada, H., Hara, T., Kawamura, N., Ariga, T., Pasic, S., Stojkovic, O., et al. (2007) · Nature · doi:10.1038/nature06096 · Cited by 1,048
Self-citationHuman C-reactive protein: expression, structure, and function
Volanakis, J. (2001) · Molecular Immunology · doi:10.1016/s0161-5890(01)00042-6 · Cited by 926
IL‐1, IL‐18, and IL‐33 families of cytokines
Arend, W. P., Palmer, G., & Gabay, C. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00624.x · Cited by 912
Pyogenic Bacterial Infections in Humans with IRAK-4 Deficiency
Picard, C., Puel, A., Bonnet, M., Ku, C.-L., Bustamante, J., Yang, K., Soudais, C., Dupuis, S., Feinberg, J., Fieschi, C., et al. (2003) · Science · doi:10.1126/science.1081902 · Cited by 826
Self-citationThe neonatal blood count in health and disease.I. Reference values for neutrophilic cells
Manroe, B. L., Weinberg, A. G., Rosenfeld, C. R., & Browne, R. (1979) · The Journal of Pediatrics · doi:10.1016/s0022-3476(79)80096-7 · Cited by 780
Combined Immunodeficiency Associated with DOCK8 Mutations
Zhang, Q., Davis, J. C., Lamborn, I. T., Freeman, A. F., Jing, H., Favreau, A. J., Matthews, H. F., Davis, J., Turner, M. L., Uzel, G., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0905506 · Cited by 742
Self-citationHerpes Simplex Virus Encephalitis in Human UNC-93B Deficiency
Casrouge, A., Zhang, S.-Y., Eidenschenk, C., Jouanguy, E., Puel, A., Yang, K., Alcais, A., Picard, C., Mahfoufi, N., Nicolas, N., et al. (2006) · Science · doi:10.1126/science.1128346 · Cited by 725
Self-citationMutations in STAT3 and IL12RB1 impair the development of human IL-17–producing T cells
de Beaucoudrey, L., Puel, A., Filipe-Santos, O., Cobat, A., Ghandil, P., Chrabieh, M., Feinberg, J., von Bernuth, H., Samarina, A., Jannière, L., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080321 · Cited by 439
Self-citationKu, C.-L., von Bernuth, H., Picard, C., Zhang, S.-Y., Chang, H.-H., Yang, K., Chrabieh, M., Issekutz, A. C., Cunningham, C. K., Gallin, J., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070628 · Cited by 399
Self-citationCourtois, G., Smahi, A., Reichenbach, J., Döffinger, R., Cancrini, C., Bonnet, M., Puel, A., Chable-Bessia, C., Yamaoka, S., Feinberg, J., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18714 · Cited by 376
Self-citationApproaching the Asymptote: 20 Years Later
Medzhitov, R. (2009) · Immunity · doi:10.1016/j.immuni.2009.06.004 · Cited by 373
Wernette, C. M., Frasch, C. E., Madore, D., Carlone, G., Goldblatt, D., Plikaytis, B., Benjamin, W., Quataert, S. A., Hildreth, S., Sikkema, D. J., et al. (2003) · Clinical and Vaccine Immunology · doi:10.1128/cdli.10.4.514-519.2003 · Cited by 337
Primary Immunodeficiencies: A Field in Its Infancy
Casanova, J.-L., & Abel, L. (2007) · Science · doi:10.1126/science.1142963 · Cited by 320
Self-citationYang, K., Puel, A., Zhang, S., Eidenschenk, C., Ku, C.-L., Casrouge, A., Picard, C., von Bernuth, H., Senechal, B., Plancoulaine, S., et al. (2005) · Immunity · doi:10.1016/j.immuni.2005.09.016 · Cited by 272
Self-citationMedvedev, A. E., Lentschat, A., Kuhns, D. B., Blanco, J. C. G., Salkowski, C., Zhang, S., Arditi, M., Gallin, J. I., & Vogel, S. N. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030701 · Cited by 261
Self-citationInterleukin-1β and the Autoinflammatory Diseases
Dinarello, C. A. (2009) · New England Journal of Medicine · doi:10.1056/nejme0811014 · Cited by 226
Qin, J., Qian, Y., Yao, J., Grace, C., & Li, X. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501363200 · Cited by 223
IRAK-4 as the central TIR signaling mediator in innate immunity
Suzuki, N., Suzuki, S., & Yeh, W.-C. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02298-6 · Cited by 220
Inborn errors of immunity to infection
Casanova, J.-L., & Abel, L. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050854 · Cited by 187
Self-citationInherited disorders of NF-κB-mediated immunity in man
Puel, A., Picard, C., Ku, C.-L., Smahi, A., & Casanova, J.-L. (2004) · Current Opinion in Immunology · doi:10.1016/j.coi.2003.11.013 · Cited by 186
Self-citationHuman genetics of infectious diseases: between proof of principle and paradigm
Alcaïs, A., Abel, L., & Casanova, J.-L. (2009) · Journal of Clinical Investigation · doi:10.1172/jci38111 · Cited by 182
Self-citationWynn, J. L., Scumpia, P. O., Winfield, R. D., Delano, M. J., Kelly-Scumpia, K., Barker, T., Ungaro, R., Levy, O., & Moldawer, L. L. (2008) · Blood · doi:10.1182/blood-2008-01-130500 · Cited by 175
Self-citationBelderbos, M. E., van Bleek, G. M., Levy, O., Blanken, M. O., Houben, M. L., Schuijff, L. S., Kimpen, J. L. L., & Bont, L. (2009) · Clinical Immunology · doi:10.1016/j.clim.2009.07.003 · Cited by 159
Self-citationPrimary immunodeficiencies associated with pneumococcal disease
Pïcard, C., Puel, A., Bustamante, J. C., Ku, C., & Casanova, J. (2003) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/00130832-200312000-00006 · Cited by 155
Self-citationIRAK4 and NEMO mutations in otherwise healthy children with recurrent invasive pneumococcal disease
Ku, C., Pïcard, C., Erdös, M., Jeurissen, A., Bustamante, J. C., Puel, A., von Bernuth, H., Filipe‐Santos, O., Chang, H., Lawrence, T., et al. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2006.044446 · Cited by 144
Self-citationThe Same IκBα Mutation in Two Related Individuals Leads to Completely Different Clinical Syndromes
Janssen, R., van Wengen, A., Hoeve, M. A., ten Dam, M., van der Burg, M., van Dongen, J. J. M., van de Vosse, E., van Tol, M., Bredius, R. G. M., Ottenhoff, T. H. M., et al. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20040773 · Cited by 137
Novel primary immunodeficiencies revealed by the investigation of paediatric infectious diseases
Bustamante, J. C., Boisson‐Dupuis, S., Jouanguy, E., Pïcard, C., Puel, A., Abel, L., & Casanova, J. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.10.005 · Cited by 134
Self-citationInterleukin 12 deficiency associated with recurrent infections
Haraguchi, S., Day, N. K. B., Nelson, R. P., Emmanuel, P. J., Duplantier, J. E., Christodoulou, C. S., & Good, R. A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.22.13125 · Cited by 106
Endotoxin and IL-1 hyporesponsiveness in a patient with recurrent bacterial infections
Kuhns, D. B., Priel, D. A. L., & Gallin, J. I. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.8.3959 · Cited by 101
Self-citationLópez‐Granados, E., Keenan, J. E., Kinney, M. C., Leo, H. L., Jain, N., Ma, C. A., Quinones, R., Gelfand, E. W., & Jain, A. (2008) · Human Mutation · doi:10.1002/humu.20740 · Cited by 99
McDonald, D. R., Mooster, J. L., Reddy, M., Bawle, E. V., Secord, E. A., & Geha, R. S. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.08.035 · Cited by 80
Self-citationMendelian traits that confer predisposition or resistance to specific infections in humans
Pïcard, C., Casanova, J., & Abel, L. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2006.05.005 · Cited by 71
Self-citationHoarau, C., Gérard, B., Lescanne, E., Henry, D., François, S., Lacapère, J.-J., Benna, J. E., Dang, P. M., Grandchamp, B., Lebranchu, Y., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.7.4754 · Cited by 69
Self-citationIRAK-4 – a shared NF-κB activator in innate and acquired immunity
Suzuki, N., & Saito, T. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.10.003 · Cited by 67
Borgers, H., Moens, L., Pïcard, C., Jeurissen, A., Raes, M., Sauer, K., Proesmans, M., Boeck, K. D., Casanova, J., Meyts, I., et al. (2009) · Clinical Immunology · doi:10.1016/j.clim.2009.10.006 · Cited by 65
Self-citationMold, C., & Clos, T. W. D. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.12.7598 · Cited by 60
Toll-Like Receptor Responses in IRAK-4-Deficient Neutrophils
van Bruggen, R., Drewniak, A., Tool, A. T. J., Jansen, M. H., van Houdt, M., Geissler, J., van den Berg, T. K., Chapel, H. M., & Kuijpers, T. W. (2009) · Journal of Innate Immunity · doi:10.1159/000268288 · Cited by 50
Self-citationAutosomal recessive Interleukin-1 receptor-associated kinase 4 deficiency in fourth-degree relatives
Cárdenes, M., von Bernuth, H., García-Saavedra, A., Santiago, E., Puel, A., Ku, C., Emile, J., Pïcard, C., Casanova, J., Colino, E., et al. (2006) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2005.12.012 · Cited by 49
Self-citationDavidson, D. J., Currie, A. J., Bowdish, D. M. E., Brown, K. L., Rosenberger, C. M., Rebecca, C., Bylund, J., Campsall, P. A., Puel, A., Pïcard, C., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.11.8202 · Cited by 45
Self-citationMcDonald, D. R., Brown, D., Bonilla, F. A., & Geha, R. S. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.08.006 · Cited by 28
Self-citation
Cited by
Toll-like Receptors and the Control of Immunity
Fitzgerald, K. A., & Kagan, J. C. (2020) · Cell · doi:10.1016/j.cell.2020.02.041 · Cited by 2,168
Kinase drug discovery 20 years after imatinib: progress and future directions
Cohen, P., Cross, D., & Jänne, P. A. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00195-4 · Cited by 1,024
Practice parameter for the diagnosis and management of primary immunodeficiency
Bonilla, F. A., Khan, D. A., Ballas, Z. K., Chinen, J., Frank, M. M., Hsu, J. T., Keller, M., Kobrynski, L. J., Komarow, H. D., Mazer, B., et al. (2015) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.04.049 · Cited by 791
Self-citationNeutrophils: Between Host Defence, Immune Modulation, and Tissue Injury
Kruger, P., Saffarzadeh, M., Weber, A. N. R., Rieber, N., Radsak, M., von Bernuth, H., Benarafa, C., Roos, D., Skokowa, J., & Hartl, D. (2015) · PLOS Pathogens · doi:10.1371/journal.ppat.1004651 · Cited by 657
Self-citationToll-like receptors in immunity and inflammatory diseases: Past, present, and future
Vijay, K. (2018) · International Immunopharmacology · doi:10.1016/j.intimp.2018.03.002 · Cited by 643
Metadata
- Authors
- Picard, C., von Bernuth, H., Ghandil, P., Chrabieh, M., Levy, O., Arkwright, P. D., McDonald, D., Geha, R. S., Takada, H., Krause, J. C., Creech, C. B., Ku, C.-L., Ehl, S., Maródi, L., Al-Muhsen, S., Al-Hajjar, S., Al-Ghonaium, A., Day-Good, N. K., Holland, S. M., Gallin, J. I., Chapel, H., Speert, D. P., Rodriguez-Gallego, C., Colino, E., Garty, B.-Z., Roifman, C., Hara, T., Yoshikawa, H., Nonoyama, S., Domachowske, J., Issekutz, A. C., Tang, M., Smart, J., Zitnik, S. E., Hoarau, C., Kumararatne, D. S., Thrasher, A. J., Davies, E. G., Bethune, C., Sirvent, N., de Ricaud, D., Camcioglu, Y., Vasconcelos, J., Guedes, M., Vitor, A. B., Rodrigo, C., Almazán, F., Méndez, M., Aróstegui, J. I., Alsina, L., Fortuny, C., Reichenbach, J., Verbsky, J. W., Bossuyt, X., Doffinger, R., Abel, L., Puel, A., & Casanova, J.-L.
- Venue
- Medicine
- Published
- 2010-11
- Volume
- 89
- Issue
- 6
- Pages
- 403-425
- ISSN
- 0025-7974 (ISSN-L)
- OpenAlex
- W2087098495
- Cited by
- 426
- References
- 44
- FWCI
- 10.54
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.